| CircHDAC9 regulates myocardial ischemia-reperfusion injury via miR-671-5p/SOX4 signaling axis. | CircHDAC9 regulates myocardial ischemia-reperfusion injury via miR-671-5p/SOX4 signaling axis.
Liu Q, Hu Y, Jie H, Lu W, Chen Y, Xing X, Tang B, Xu G, Sun J, Liang Y. | 04/5/2024 |
| Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes. | Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes.
Liu J, Meng L, Liu Z, Lu M, Wang R., Free PMC Article | 04/5/2024 |
| Histone deacetylase 9-mediated phenotypic transformation of vascular smooth muscle cells is a potential target for treating aortic aneurysm/dissection. | Histone deacetylase 9-mediated phenotypic transformation of vascular smooth muscle cells is a potential target for treating aortic aneurysm/dissection.
Dang Z, Li H, Xue S, Shao B, Ning Y, Su G, Zhang F, Yu W, Leng S. | 03/27/2024 |
| Endothelial beta-catenin upregulation and Y142 phosphorylation drive diabetic angiogenesis via upregulating KDR/HDAC9. | Endothelial β-catenin upregulation and Y142 phosphorylation drive diabetic angiogenesis via upregulating KDR/HDAC9.
Chen Z, Lin B, Yao X, Weng J, Liu J, He Q, Song K, Zhou C, Zuo Z, Huang X, Liu Z, Huang Q, Xu Q, Guo X., Free PMC Article | 03/18/2024 |
| HDAC9-mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease. | HDAC9-mediated calmodulin deacetylation induces memory impairment in Alzheimer's disease.
Zhang HL, Hu S, Yang P, Long HC, Ma QH, Yin DM, Xu GY., Free PMC Article | 03/1/2024 |
| HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD. | HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD.
Zheng G, Li C, Chen X, Deng Z, Xie T, Huo Z, Wei X, Huang Y, Zeng X, Luo Y, Bai J. | 02/21/2024 |
| Aberrant expression and regulatory role of histone deacetylase 9 in vascular endothelial cell injury in intracranial aneurysm. | Aberrant expression and regulatory role of histone deacetylase 9 in vascular endothelial cell injury in intracranial aneurysm.
Sun J, Zhang L, Cheng Q, Wu Y., Free PMC Article | 01/12/2024 |
| Role of histone deacetylase 9 in human periodontal ligament stem cells autophagy in a tumour necrosis factor alpha-induced inflammatory environment. | Role of histone deacetylase 9 in human periodontal ligament stem cells autophagy in a tumour necrosis factor α-induced inflammatory environment.
Ge W, Luo S, Zhang K, Liu L, Zhou Z, Liu Y. | 09/7/2023 |
| Reverse expression pattern of sirtuin-1 and histone deacetylase-9 in coronary artery disease. | Reverse expression pattern of sirtuin-1 and histone deacetylase-9 in coronary artery disease.
Heidari L, Ghaderian SMH, Bastami M, Hosseini S, Alipour Parsa S, Heidari S, Jafari H, Sohrabifar N, Pirhoushiaran M. | 02/14/2023 |
| Sex-Dependent Role of Adipose Tissue HDAC9 in Diet-Induced Obesity and Metabolic Dysfunction. | Sex-Dependent Role of Adipose Tissue HDAC9 in Diet-Induced Obesity and Metabolic Dysfunction.
Goo B, Ahmadieh S, Zarzour A, Yiew NKH, Kim D, Shi H, Greenway J, Cave S, Nguyen J, Aribindi S, Wendolowski M, Veerapaneni P, Ogbi M, Chen W, Lei Y, Lu XY, Kim HW, Weintraub NL., Free PMC Article | 10/8/2022 |
| Downregulation of HDAC9 by the ketone metabolite beta-hydroxybutyrate suppresses vascular calcification. | Downregulation of HDAC9 by the ketone metabolite β-hydroxybutyrate suppresses vascular calcification.
Lan Z, Chen A, Li L, Ye Y, Liang Q, Dong Q, Wang S, Fu M, Li Y, Liu X, Zhu Z, Ou JS, Qiu X, Lu L, Yan J. | 10/8/2022 |
| HDAC9 structural variants disrupting TWIST1 transcriptional regulation lead to craniofacial and limb malformations. | HDAC9 structural variants disrupting TWIST1 transcriptional regulation lead to craniofacial and limb malformations.
Hirsch N, Dahan I, D'haene E, Avni M, Vergult S, Vidal-García M, Magini P, Graziano C, Severi G, Bonora E, Nardone AM, Brancati F, Fernández-Jaén A, Rory OJ, Hallgrímsson B, Birnbaum RY., Free PMC Article | 08/6/2022 |
| HDAC9 exacerbates myocardial infarction via inactivating Nrf2 pathways. | HDAC9 exacerbates myocardial infarction via inactivating Nrf2 pathways.
Liu F, Di Y, Ma W, Kang X, Li X, Ji Z. | 07/23/2022 |
| Knockdown of HDAC9 Inhibits Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Partially by Suppressing the MAPK Signaling Pathway. | Knockdown of HDAC9 Inhibits Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Partially by Suppressing the MAPK Signaling Pathway.
Wang B, Gong S, Han L, Shao W, Li Z, Xu J, Lv X, Xiao B, Feng Y., Free PMC Article | 05/28/2022 |
| An HDAC9-associated immune-related signature predicts bladder cancer prognosis. | An HDAC9-associated immune-related signature predicts bladder cancer prognosis.
Fu Y, Sun S, Bi J, Kong C, Shi D., Free PMC Article | 05/7/2022 |
| HDAC9 in the Injury of Vascular Endothelial Cell Mediated by P38 MAPK Pathway. | HDAC9 in the Injury of Vascular Endothelial Cell Mediated by P38 MAPK Pathway.
Kuang X, Chen S, Lao J, Chen Y, Jia D, Tu L, Ma L, Liao X, Zhao W, Li Q. | 03/19/2022 |
| Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway. | Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway.
Zuo X, Fu C, Xie J, Wang X, Yan Z. | 03/5/2022 |
| Hsa_circ_0001879 promotes the progression of atherosclerosis by regulating the proliferation and migration of oxidation of low density lipoprotein (ox-LDL)-induced vascular endothelial cells via the miR-6873-5p-HDAC9 axis. | Hsa_circ_0001879 promotes the progression of atherosclerosis by regulating the proliferation and migration of oxidation of low density lipoprotein (ox-LDL)-induced vascular endothelial cells via the miR-6873-5p-HDAC9 axis.
Li F, Chen Y, He Z, Wang C, Wang X, Pan G, Peng JY, Chen Q, Wang X., Free PMC Article | 02/19/2022 |
| Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer. | Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer.
Yang C, Croteau S, Hardy P., Free PMC Article | 02/12/2022 |
| Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11. | Histone deacetylase 9 inhibition upregulates microRNA-92a to repress the progression of intracranial aneurysm via silencing Bcl-2-like protein 11.
Cai Y, Huang D, Ma W, Wang M, Qin Q, Jiang Z, Liu M. | 01/8/2022 |
| Knockdown of long noncoding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR36195p to target HDAC9. | Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9.
Zhu Y, Hao F. | 11/13/2021 |
| Interactive Effects of a Combination of the HDAC3 and HDAC9 Genes with Diabetes Mellitus on the Risk of Ischemic Stroke. | Interactive Effects of a Combination of the HDAC3 and HDAC9 Genes with Diabetes Mellitus on the Risk of Ischemic Stroke.
Chiou HY, Bai CH, Lien LM, Hu CJ, Jeng JS, Tang SC, Lin HJ, Hsieh YC. | 10/30/2021 |
| IL-4 inhibits regulatory T cells differentiation by HDAC9-mediated epigenetic regulation. | IL-4 inhibits regulatory T cells differentiation by HDAC9-mediated epigenetic regulation.
Cui J, Xu H, Yu J, Li Y, Chen Z, Zou Y, Zhang X, Du Y, Xia J, Wu J., Free PMC Article | 10/16/2021 |
| HDAC9 rs11984041 polymorphism is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes mellitus. | HDAC9 rs11984041 polymorphism is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes mellitus.
Cilenšek I, Lapuh V, Globočnik Petrovič M, Petrovič D. | 07/24/2021 |
| Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma. | Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma.
Fu Y, Piao C, Zhang Z, Zhu Y, Sun S, Bi J, Kong C, Ju M. | 07/24/2021 |